Getting balance: Drugs for bipolar disorder share target

Nature Medicine

Volumn 8, Issue 6, 2002, Pages 557-558

  Coyle, Joseph T ^a   Manji, Husseini K ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; GLYCOGEN SYNTHASE KINASE 3; LITHIUM; NEUROLEPTIC AGENT; PROTEIN KINASE C; VALPROIC ACID;

DRUG EFFECT; DRUG MECHANISM; DRUG RESISTANCE; GENE MUTATION; GROWTH CONE; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANTICONVULSANTS; BIPOLAR DISORDER; HUMANS; LITHIUM; MODELS, NEUROLOGICAL; SIGNAL TRANSDUCTION;

EID: 0036278008     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0602-557     Document Type: Article

References (11)

1. A common mechanism of action for three mood-stabilizing drugs
2. Neural and developmental actions of lithium: A unifying hypothesis
3. Chen MAP kinases and the bcl-2 family of proteins as long term targets for mood stabilizers
4. Overview of the mechanism of action of lithium in the brain: Fifty-year update
5. Convergent functional genomics: Application to bipolar disorder
6. A molecular mechanism for the effect of lithium on development
7. Alterations in plasma prolyl endopeptidase activity in depression, mania and schizophrenia; effects of antidepressants, mood stabilizers and antipsychotic drugs
8. Synaptic plasticity and mood disorders
9. Neuroimaging and neuropathological studies of depression: Implications for the cognitive-emotional features of mood disorders
10. Evidence for the involvement of the MAP/ERK signaling cascade in mood modulation
11. N-acetylaspartate in neuropsychiatric disorders